CONTACT US
News and Stories About neuroendocrine tumors
FDA Approves New Treatment for PNETs: What You Need to Know
The U.S. Food & Drug Administration has granted approval for a new drug to treat pancreatic neuroendocrine tumors, also called […]
READ MORE
Full-Body MRI: What You Need to Know
Maria Menounos has been talking about full-body MRIs in interviews and on social media.
Recap of the Largest-Ever American Society of Clinical Oncology Meeting
Clinical trial results and PanCAN’s initiatives were highlighted at major meeting.
Remembering Steve Jobs
The tech icon died of pancreatic neuroendocrine cancer, a rare form of the disease.
Survivor Makes Positivity the Face of this Disease
Editor’s Note: We are saddened at the passing of Robyn Hobson on February 21, 2023. PanCAN sends deepest sympathies and […]
READ MORE
Moments Matter: Joe LaRose
His wife saved his life. Joe LaRose gives credit for his early pancreatic cancer diagnosis to her – he had […]
READ MORE
PNET Survivor Receives ‘Gift’ Through Molecular Profiling
The morning of Feb. 5, 2016, started like many for Gail. She got up early and headed to the gym […]
READ MORE
2018 Year in Review: Top 10 Pancreatic Cancer News Stories
Editor’s note: Today’s edition of the 2018 Year in Review series features the 10 most popular news stories on the […]
READ MORE
PanCAN Fights PNETs – the Cancer that Took Aretha Franklin’s Life
“Respect.” “(You Make Me Feel Like a) Natural Woman.” “I Say a Little Prayer.” Aretha Franklin’s velvety, smooth melodies became […]
READ MORE
Aretha Franklin, the “Queen of Soul,” Dies of Pancreatic Neuroendocrine Cancer
The family of Aretha Franklin confirmed Thursday that the 18-time Grammy Award-winning singer and songwriter best known for hits like […]
READ MORE
Lutathera®: A PNET Survivor Story
A type of treatment that doctors in Europe have administered for more than a decade is now available for use […]
READ MORE
FDA Approves Lutathera® for Pancreatic Neuroendocrine Tumors (PNETs)
MANHATTAN BEACH, Calif. – The Pancreatic Cancer Action Network is excited to share that the FDA just approved Lutathera®, a medication effective for somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including pancreatic neuroendocrine tumors (PNETs).
Lutathera® Drug Approved for Pancreatic Neuroendocrine Tumors
Today, the U.S. Food & Drug Administration (FDA) approved Lutathera® (lutetium-177 (177Lu)-Dotatate) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), […]
READ MORE
In Quest to Understand His Father’s Illness, a Young Doctor Discovers His Own
In August 2017, oncologist Mark Lewis, MD, underwent a Whipple surgical procedure for his pancreatic neuroendocrine tumor (PNET). But his […]
READ MORE
Steve Jobs: Still Innovating, Six Years Later
Today marks six years since Apple co-founder Steve Jobs passed away from pancreatic cancer. He was 56. Jobs suffered from […]
READ MORE
